Cell nucleus | Soft Cell | Cell biology | Cell | cell | cell (biology) | B-cell activating factor | Cell (journal) | Cell (biology) | T cell | cell membrane | Mesenchymal stem cell | Cell membrane | Hematopoietic stem cell transplantation | cell culture | Cell Biology | The Plant Cell | Solar cell | Photoreceptor cell | fuel cell | Cell (Dragon Ball) | X-Cell | White blood cell | Tom Clancy's Splinter Cell (video game) | The Cell | The Ancestor Cell | Stem cell controversy | Red Cell | Red blood cell | Proton exchange membrane fuel cell |
In 2003, Cell Therapeutics, a Seattle biotechnology company, acquired pixantrone through a merger with Novuspharma.
Dr. Bellini is also a member of the following Board of Directors: Molson Coors Brewing Company; Montreal Heart Institute Foundation; Italian Chamber of Commerce; the Government of Canada's Science Technology & Innovation Council; and Stem Cell Therapeutics Corp.